Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease

BACKGROUND: The vast majority of mitochondrial disorders have limited the clinical management to palliative care. Rapamycin has emerged as a potential therapeutic drug for mitochondrial diseases since it has shown therapeutic benefits in a few mouse models of mitochondrial disorders. However, the un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Barriocanal-Casado, Eliana, Hidalgo-Gutiérrez, Agustín, Raimundo, Nuno, González-García, Pilar, Acuña-Castroviejo, Darío, Escames, Germaine, López, Luis C.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492073/
https://ncbi.nlm.nih.gov/pubmed/30898651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.03.025
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados